Aug 09, 2024 3:38 pm EDT Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering
Aug 06, 2024 8:45 am EDT Scorpius Holdings Weighted-Average Pipeline Surpasses $100 Million in Business Develop Opportunities Across Both Manufacturing Client and Government Sectors
Jul 30, 2024 8:00 am EDT Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024
Jul 24, 2024 8:30 am EDT Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
Jun 17, 2024 8:00 am EDT Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
Jun 03, 2024 8:00 am EDT Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
May 29, 2024 7:00 am EDT Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
May 20, 2024 8:00 am EDT Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
May 16, 2024 8:00 am EDT Scorpius Holdings Commends Congress on Bipartisan Legislative Action Aimed at Bolstering U.S. Biomanufacturing